Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank93
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
39.72%
↑ 138% vs avg
Percentile
P93
Near historical high
Streak
1 yr
Consecutive growthAccelerating
Average
-105.37%
Historical baseline
PeriodValue
202539.72%
2024-30.85%
2023-29.61%
2022-21.07%
2021-17.53%
2020-117.24%
2019-134.75%
2018-26.88%
2017-27.64%
2016-687.83%